ErlySign – Non‑Invasive, Affordable Oral Cancer Detection

Driven by Discovery. Defined by Purpose.

Reimagining early cancer detection with breakthrough technology that’s affordable, fast, and life-saving.

From Research to Real Impact

We bridge the gap between scientific innovation and everyday healthcare. Our work doesn’t end in the lab it begins there, empowering real-world change through accessible, life-saving technologies.

At the Heart of Breakthroughs

Our 4 Key Pillars

Precision Science

Built on deep clinical

validation

Frictionless Experience

Early detection for real-world clinics

Affordable Access

Cutting edge, minus the

cost

Scalable Vision

Designed for global health systems

Our Vision

We envision a future where every individual, no matter where they live, has access to early and reliable cancer screenings. Through technology, research, and global partnerships, we aim to become the most trusted name in early stage cancer detection worldwide.

Our Mission

We are on a mission to make early detection of life-threatening diseases simple, painless, and accessible. By harnessing saliva-based diagnostics, we aim to empower medical professionals and individuals to act early when it matters most. Starting with oral cancer, we’re building a path toward broader, scalable solutions for global health.

Core Values

At ErlySign, we are driven by purpose and powered by innovation. Our commitment to accessibility, scientific integrity, and meaningful impact guides everything we do from research to real world deployment. We believe in collaboration, empathy, and creating technology that genuinely improves lives.

Early detection is no longer optional, it's critical

India accounts for over one-third of global cases

Global vs. India: Oral Cancer Burden (2024–2025)

India 36.9%

Global (approx. 389,846)*

0 %

(approx. 143,759)*

of global oral cancer cases occur in India.

India’s Alarming Share : New cases vs Mortality (2024-2025)

Mortality 53.6%

New cases (approx. 143,759)*

*Above mentioned numbers are approximate and are not definite

0 %

(approx. 77,000)*

mortality rate of oral cancer cases in India

Why ErlySign Stands Apart

We’re not just another diagnostic solution we’re a movement redefining early cancer detection.

01

Revolutionary Non-Invasive Tech

No needles, no pain our breakthrough screening method uses painless swabs and delivers lab-grade results, faster than ever.

02

Clinically Validated Accuracy

Backed by robust data, peer-reviewed studies, and real-world trials. We deliver science you can trust.

03

Scalable Across Geographies

Urban hospitals, rural clinics, or mobile camps our solution adapts to infrastructure, no matter the setting.

04

Cost-Effective & Inclusive

Priced for scale without compromising quality. Our mission ensures affordability doesn’t mean sacrifice.

05

Plug-and-Play Simplicity

Minimal training required. Healthcare professionals can integrate ErlySign with zero operational friction.

06

Future-Ready Platform

Our diagnostic engine is modular built for oral cancer today, scalable for tomorrow’s diseases.

Be the change. Be the breakthrough

The Silent Killer

Oral cancer is one of India’s deadliest yet most preventable cancers.

A New Hope

With ErlySign, early detection becomes a reality even in remote areas.

The Minds Behind the Mission

Our team brings together scientists, clinicians, engineers, and changemakers all committed to redefining early cancer detection through collaboration, compassion, and cutting edge technology.

Shubhendra Singh Thakur

CEO & Founder

Dr Deovrat Begde

Chief Scientific Officer & Cofounder

Dr. Aparna Nair

Scientific Team Lead

Sheetal Dongarwar

Junior Research Associate

Sharvari Kshirsagar

Junior Research Associate

Deeksha Shakya

Junior Research Associate

Prajakta Ashtaputre

Research Associate

Join the Mission, Shape the Future

We’re building the future of early detection—one breakthrough at a time. If you’re driven by purpose, innovation, and impact, ErlySign is where you belong.

Powering a Nationwide Network of Innovation

From top hospitals to local medical shops, our partners are transforming early detection with ErlySign’s advanced screening technology.

What is Erlysign?

Erlysign is a non invasive early detection test kit for detecting Oral precancerous conditions at an early stage.

What kind of test is it?

This is a semi quantitative test in which we check for biomarkers in one’s saliva sample to assess the risk of pre cancerous conditions .The results can be quantified as Low - Moderate - High depending on the assessment.

Does this test confirm that I have cancer?

No this is an early detection test and is meant to assess the risk of oral precancerous conditions and its ongoing or future development. This test is not meant to diagnose the cancer.Only Biopsies can confirm the cancer.

How accurate is the oral cancer detection kit?

Our kit offers 98.04% clinically validated accuracy, making it a highly reliable non-invasive detection tool.

Frequently Asked Questions

Get quick answers about our early detection solution and partnership opportunities.

Driven by Discovery. Defined by Purpose.

From Research to Real Impact

At the Heart of Breakthroughs

Our Vision

Our Mission

Core Values

Early detection is no longer optional, it's critical

Why ErlySign Stands Apart

01

02

03

04

05

06

Be the change. Be the breakthrough

The Silent Killer

A New Hope

The Minds Behind the Mission

Shubhendra Singh Thakur

Dr Deovrat Begde

Dr. Aparna Nair

Sheetal Dongarwar

Sharvari Kshirsagar

Deeksha Shakya

Prajakta Ashtaputre

Join the Mission, Shape the Future

Powering a Nationwide Network of Innovation

Frequently Asked Questions

Stay Updated with ErlySign

Get Started with ErlySign